Posts

Posted on

SHAREHOLDER ALERT: WeissLaw LLP Investigates Northern Star Acquisition Corp.

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Northern Star Acquisition Corp. (“STIC” or the “Company”) (NYSE: STIC) in connection with the Company’s proposed merger with Barkbox Inc. (“Barkbox”), a privately-held subscription service for pet owners.  Under the terms of the merger agreement, STIC will acquire Barkbox through a reverse merger that will result in Barkbox becoming a public company traded on the New York Stock Exchange under the ticker symbol “BARK.”  The transaction is valued at approximately $1.6 billion.


If you own STIC shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:


https://www.weisslawllp.com/STIC/


Or please contact:



Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw is investigating whether STIC’s board acted in the best interest of STIC’s public shareholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of Barkbox, and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to STIC public shareholders. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-northern-star-acquisition-corp-301196308.html

SOURCE WeissLaw LLP

Posted on

SHAREHOLDER ALERT: WeissLaw LLP Investigates BioTelemetry, Inc.

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioTelemetry, Inc. (“BioTelemetry” or the “Company”) (NASDAQ: BEAT) in connection with the proposed acquisition of the Company by Royal Philips (NYSE: PHG).  The transaction is structured as an all-cash tender offer in which the Company’s shareholders will receive only $72.00 for each share of BioTelemetry common stock that they hold.    


If you own BioTelemetry shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:


https://www.weisslawllp.com/beat/


Or please contact:







Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw is investigating whether (i) BioTelemetry’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $72.00 per-share merger consideration adequately compensates BioTelemetry’s shareholders; and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.  Notably, an analyst has set a price target of $77.00 for BioTelemetry stock, $5.00 higher than the proposed merger consideration. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-biotelemetry-inc-301196306.html

SOURCE WeissLaw LLP

Posted on

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Tottenham Acquisition I Limited – TOTA

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Tottenham Acquisition I Limited (“Tottenham” or the “Company”) (TOTA) relating to its proposed reverse merger with Clene Nanomedicine, Inc. Under the terms of the agreement, Tottenham will acquire Clene through a reverse merger that will result in Clene becoming a publicly traded company.

The investigation focuses on whether Tottenham Acquisition I Limited and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether and by how much this proposed transaction undervalues the Company.

Click here for more information:
 

https://www.monteverdelaw.com/case/tottenham-acquisition-i-limited

.
It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders from corporate wrongdoing.   We were listed in the Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report. Our lawyers have significant Tottenham litigating Mergers & Acquisitions and Securities Class Actions.  Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.  Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019).  Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in Tottenham Acquisition I Limited and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-tottenham-acquisition-i-limited–tota-301196317.html

SOURCE Monteverde & Associates PC

Posted on

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of TPG Pace Beneficial Finance Corp. – TPGY

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating TPG Pace Beneficial Finance Corp. (“TPGY” or the “Company”) (TPGY) relating to its proposed reverse merger with EV Charged B.V. (“EVBox”). Under the terms of the agreement, TPGY will acquire EVBox through a reverse merger that will result in EVBox becoming a publicly traded company.

The investigation focuses on whether TPG Pace Beneficial Finance Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether and by how much this proposed transaction undervalues the Company.

Click here for more information:
 

https://www.monteverdelaw.com/case/tpg-pace-beneficial-finance-corp

.
It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders from corporate wrongdoing.   We were listed in the Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report. Our lawyers have significant TPGY litigating Mergers & Acquisitions and Securities Class Actions.  Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.  Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019).  Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in TPG Pace Beneficial Finance Corp. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-tpg-pace-beneficial-finance-corp–tpgy-301196315.html

SOURCE Monteverde & Associates PC

Posted on

Recro Grants Inducement Award to New Chief Executive Officer

MALVERN, Pa., Dec. 18, 2020 (GLOBE NEWSWIRE) — Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products, today announced that it granted an inducement award to its newly-appointed President and Chief Executive Officer, David Enloe.

The award consists of 217,822 restricted stock units and an option to purchase 194,175 shares of Recro’s common stock. The award was granted on December 15, 2020 pursuant to the NASDAQ inducement grant exception as a component of Mr. Enloe’s compensation and was granted as an inducement material to his acceptance of employment with Recro in accordance with NASDAQ Listing Rule 5635(c)(4). With regard to the restricted stock units, 19,802 will vest in full on December 15, 2021; 132,013 will vest in four equal annual installments beginning on December 15, 2021; and 66,007 will vest upon the achievement of certain performance-based milestones determined by the Compensation Committee of Recro, in each case subject to Mr. Enloe’s continued service with Recro through the applicable vesting date. The options will vest in equal monthly installments over 48 months, beginning on January 15, 2021, subject to Mr. Enloe’s continued service with Recro through the applicable vesting date. The options have an exercise price of $3.03 per share of Recro common stock and will expire on December 15, 2030.

About Recro

Recro is a contract development and manufacturing organization, or CDMO, with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage solid oral dose drug products. Recro’s Clinical Trials Materials and Logistics business, including preparation of double-blind clinical trial supplies and supply logistics is becoming a popular service, as well as capabilities for specialized services dedicated to the development and GMP manufacturing of high potency products. The Company leverages its formulation expertise to develop and manufacture pharmaceutical products using its proprietary delivery technologies and other manufacturing services for commercial and development-stage partners who commercialize or plan to commercialize these products. For more information see www.recrocdmo.com.

Cautionary Statement Regarding Forward Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements, among other things, relate to the Company’s ability to manage costs and to achieve its financial goals; to operate under increased leverage and associated lending covenants; to pay its debt under its credit agreement and to maintain relationships with CDMO commercial partners and develop additional commercial partnerships. The words “anticipate”, “believe”, “could”, “estimate”, “upcoming”, “expect”, “intend”, “may”, “plan”, “predict”, “project”, “will” and similar terms and phrases may be used to identify forward-looking statements in this press release. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Factors that could cause the Company’s actual outcomes to differ materially from those expressed in or underlying these forward-looking statements include the ongoing economic and social consequences of the COVID-19 pandemic, including any adverse impact on the customer ordering patterns or inventory rebalancing or disruption in raw materials or supply chain; demand for the Company’s services, which depends in part on customers’ research and development and the clinical plans and market success of their products; customers’ changing inventory requirements and manufacturing plans; customers and prospective customers decisions to move forward with the Company’s manufacturing services; the average profitability, or mix, of the products the Company manufactures; the Company’s ability to enhance existing or introduce new services in a timely manner; fluctuations in the costs, availability, and suitability of the components of the products the Company manufactures, including active pharmaceutical ingredients, excipients, purchased components and raw materials, or the Company’s customers facing increasing or new competition. These forward-looking statements should be considered together with the risks and uncertainties that may affect our business and future results presented herein along with those risks and uncertainties discussed in our filings with the Securities and Exchange Commission at www.sec.gov. These forward-looking statements are based on information currently available to us, and we assume no obligation to update any forward-looking statements except as required by applicable law.

Contacts

Investor Relations Contact:
Argot Partners
Sam Martin / Claudia Styslinger
(212) 600-1902
[email protected] 
[email protected] 

Recro
Ryan D. Lake
(484) 395-2436
[email protected] 

Media Contact:
Argot Partners
David Rosen
(212) 600-1902
[email protected] 



Posted on

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of TCF Financial Corp. – TCF

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating TCF Financial Corp. (“TCF” or the “Company”) (TCF) relating to its proposed merger with Huntington Bancshares, Inc. Under the terms of the agreement, TCF shareholders will receive 3.0028 shares of Huntington per share they own.

The investigation focuses on whether TCF Financial Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether and by how much this proposed transaction undervalues the Company.

Click here for more information:
 

https://www.monteverdelaw.com/case/tcf-financial-corp

.
It is free and there is no cost or obligation to you.

About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders from corporate wrongdoing.   We were listed in the Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report. Our lawyers have significant TCF litigating Mergers & Acquisitions and Securities Class Actions.  Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.  Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019).  Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in TCF Financial Corp. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-tcf-financial-corp–tcf-301196301.html

SOURCE Monteverde & Associates PC

Posted on

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of BioTelemetry, Inc. – BEAT

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating BioTelemetry, Inc. (“BEAT” or the “Company”) (BEAT) relating to its proposed acquisition by Royal Phillips. Under the terms of the agreement, BEAT shareholders will receive $72.00 in cash per share.

The investigation focuses on whether BioTelemetry, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether and by how much this proposed transaction undervalues the Company.

Click here for more information:
 

https://www.monteverdelaw.com/case/biotelemetry-inc

.
It is free and there is no cost or obligation to you.

About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders from corporate wrongdoing.   We were listed in the Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report. Our lawyers have significant BEAT litigating Mergers & Acquisitions and Securities Class Actions.  Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.  Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019).  Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in BioTelemetry, Inc. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-biotelemetry-inc–beat-301196304.html

SOURCE Monteverde & Associates PC

Posted on

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Cardtronics plc – CATM

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ —


Juan Monteverde
, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Cardtronics plc (“Cardtronics” or the “Company”) (CATM) relating to its proposed acquisition by affiliates of Apollo Global Management, Inc. and Hudson Executive Capital LP. Under the terms of the agreement, Cardtronics shareholders will receive $35.00 in cash per share.

The investigation focuses on whether Cardtronics plc and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether and by how much this proposed transaction undervalues the Company.

Click here for more information:
 

https://www.monteverdelaw.com/case/cardtronics-plc

.
It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders from corporate wrongdoing.   We were listed in the Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions.  Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.  Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019).  Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in Cardtronics plc and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-cardtronics-plc–catm-301196259.html

SOURCE Monteverde & Associates PC

Posted on

STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

  • HD Supply Holdings, Inc. (

    HDS

    ) relating to its proposed acquisition by The Home Depot, Inc. Under the terms of the agreement, HDS shareholders are expected to receive $56.00 per share. Click here for more information: https://www.monteverdelaw.com/case/hd-supply-holdings-inc-0. It is free and there is no cost or obligation to you.
  • PNM Resources, Inc. (

    PNM

    ) relating to its proposed acquisition by Avangrid, Inc. Under the terms of the agreement, PNM shareholders will receive $50.30 per share in cash. Click here for more information: http://monteverdelaw.com/case/pnm-resources-inc. It is free and there is no cost or obligation to you.
  • Navistar International Corporation (

    NAV

    ) relating to its proposed acquisition by TRATON SE, Inc. Under the terms of the agreement, Navistar shareholders will receive $44.50 per share in cash. Click here for more information: https://www.monteverdelaw.com/case/navistar-international-corporation. It is free and there is no cost or obligation to you.
  • SEACOR Holdings, Inc. (CKH) relating to its proposed acquisition by an affiliate of American Industrial Partners. Under the terms of the agreement, SEACOR shareholders are expected to receive $41.50 in cash per share. Click here for more information: https://www.monteverdelaw.com/case/seacor-holdings-inc. It is free and there is no cost or obligation to you.
  • Cellular Biomedicine Group, Inc. (

    CBMG
    ) relating to its sale to a consortium that includes members of CBMG management and several entities. Under the terms of the agreement, CBMG shareholders will receive $19.75 in cash for each share of CBMG stock they own. Click here for more information: https://www.monteverdelaw.com/case/cellular-biomedicine-group-inc-0. It is free and there is no cost or obligation to you.

About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders from corporate wrongdoing.  Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions.  Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.  Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019).  Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/stockholder-alert-monteverde–associates-continues-to-investigate-the-following-merger-301196302.html

SOURCE Monteverde & Associates PC

Posted on

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Experience Investment Corp. – EXPC

PR Newswire

NEW YORK, Dec. 18, 2020 /PRNewswire/ —


Juan Monteverde
, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Experience Investment Corp. (“Experience” or the “Company”) (EXPC) relating to its proposed merger with BLADE Urban Air Mobility, Inc. Under the terms of the agreement, Experience will issue a number of shares to BLADE shareholders, who in turn will own approximately 43.2% of the combined company.

The investigation focuses on whether Experience Investment Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether and by how much this proposed transaction undervalues the Company.

Click here for more information:
 

https://www.monteverdelaw.com/case/experience-investment-corp

.
It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders from corporate wrongdoing.   We were listed in the Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions.  Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.  Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019).  Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in Experience Investment Corp. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-experience-investment-corp–expc-301196258.html

SOURCE Monteverde & Associates PC